ICAM1 and Insulin resistance: Other studies have shown that astaxanthin could modulate the glycemic state and decrease insulin resistance, also exerting anti-inflammatory and anti-angiogenic effects by decreasing the expression of NF-κB and TNF-α, finally inhibiting the expression of proinflammatory molecules such as ICAM-1 and VEGF [144].